FFCP PHASE1:Mm9::chr2:38392125..38392136,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=2724|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr2:38392125..38392136,+|id=chr2:38392125..38392136,+|ontology_enrichment_celltype=CL:0002320!1.07e-08!46;CL:0000134!1.07e-08!46;CL:0000988!1.07e-07!32;CL:0002032!1.07e-07!32;CL:0000037!1.07e-07!32;CL:0000566!1.07e-07!32;CL:0000837!1.07e-07!32;CL:0000049!1.32e-07!19;CL:0000063!6.41e-07!66|ontology_enrichment_celltype_v019_2=CL:0000049,7.99e-15,19;CL:0000764,2.53e-12,3;CL:0000765,2.53e-12,3;CL:0000038,2.53e-12,3;CL:0000547,2.53e-12,3;CL:0002092,3.93e-12,3;CL:0002540,3.93e-12,3;CL:0002320,1.12e-11,46;CL:0000134,1.12e-11,46;CL:0000034,3.05e-11,97;CL:0000219,1.31e-09,54;CL:0000988,2.91e-08,32;CL:0002032,2.91e-08,32;CL:0000037,2.91e-08,32;CL:0000837,2.91e-08,32;CL:0000763,3.97e-08,16;CL:0000723,6.12e-08,91;CL:0000048,6.12e-08,91|ontology_enrichment_disease=DOID:0050686!1.05e-09!6|ontology_enrichment_disease_v019_2=DOID:0050686,2.83e-23,6;DOID:0060100,1.35e-12,3;DOID:4045,1.35e-12,3;DOID:2531,2.53e-12,3;DOID:0060083,2.53e-12,3;DOID:1240,2.53e-12,3|ontology_enrichment_uberon=UBERON:0002384!1.07e-08!46|ontology_enrichment_uberon_v019_2=UBERON:0002384,1.12e-11,46;UBERON:0002204,2.03e-08,32;UBERON:0002371,4.63e-08,16|phase1_expression=0.160148847104794,0,0,0.30246421130683,0,0,0,0.387369970324729,0,0.234064526321993,0,0,0,0,0,0,0,0,0,0,0,0.297872853602656,0.261199789138935,0,0.45881856213434,0,0,0.215471232685889,0,0,0.221730510655305,1.90509202037889,1.23012957516914,15.8481681015439,0,0,0,2.92972141515835,3.1253413780952,2.09409497589519,8.2352408324342,9.56263678941824,1.45653105909346,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,1.7997994345628,3.9554654502679,1.4209602298922,0.299600110518405,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.294628585473668,0,0.186399445825301,0,0,1.73918693221007,0,0.679971333707751,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0,0,0,0,0,0,0,0,0,0.117588707135705,0,0,0,0,0,0,0,0,0,0,0,1.67741174308288,2.39961092397363,1.01656181658452,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0937017245597288,0,0,0,0,0,0,0,0.411564272815887,0,2.1066395619397,1.28673953557358,0.568326998791185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.102904612379284,0,0.264450566663544,0,0,0,0,0,0.190225626112559,0,0,0,0,0,0.898819408654221,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.224862112384854,0.202860121388503,0.241177159752417,0.50925170356284,0.287696137450811,0,0.274561413188081,0,0,0,0,0,0,0,0,0,0.169745085775188,0,0,0,0,0,0,0,0,0,0.144649058581512,1.50791283939272,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164970122972535,0,0,0,0,0,0,0,0,0.356497378384721,0,0,0,2.7235168460303,0,0,0,0,0.178368817602071,0,0.608929898229199,0,0,0,0,0,0,0,0,0.291480836629851,0,0,0,0.555583582109135,0,0,0,6.11922347977879,6.9975726161829,4.28419918793714,0,0,0,0,0,0,0.134864346384821,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.183151624267265,0.428736758158132,0,0,0,0,0.171853182343688,0,0,0,0,0,0,0,0,0,0,0,0.367687016900028,0.222246727801615,0,0,0,0,0,0.0936415074698824,0,0.114870937911227,0,0,0,0,0,0,0,0,0.145346416632329,0,0.0846146078916765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr2:38392125..38392136,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=2724 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr2:38392125..38392136,+ | |||
|description=CAGE_peak_at_chr2:38392125..38392136,+ | |||
|id=chr2:38392125..38392136,+ | |||
|ontology_enrichment_celltype=CL:0002320!1.07e-08!46;CL:0000134!1.07e-08!46;CL:0000988!1.07e-07!32;CL:0002032!1.07e-07!32;CL:0000037!1.07e-07!32;CL:0000566!1.07e-07!32;CL:0000837!1.07e-07!32;CL:0000049!1.32e-07!19;CL:0000063!6.41e-07!66 | |||
|ontology_enrichment_celltype_v019_2=CL:0000049,7.99e-15,19;CL:0000764,2.53e-12,3;CL:0000765,2.53e-12,3;CL:0000038,2.53e-12,3;CL:0000547,2.53e-12,3;CL:0002092,3.93e-12,3;CL:0002540,3.93e-12,3;CL:0002320,1.12e-11,46;CL:0000134,1.12e-11,46;CL:0000034,3.05e-11,97;CL:0000219,1.31e-09,54;CL:0000988,2.91e-08,32;CL:0002032,2.91e-08,32;CL:0000037,2.91e-08,32;CL:0000837,2.91e-08,32;CL:0000763,3.97e-08,16;CL:0000723,6.12e-08,91;CL:0000048,6.12e-08,91 | |||
|ontology_enrichment_disease=DOID:0050686!1.05e-09!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0050686,2.83e-23,6;DOID:0060100,1.35e-12,3;DOID:4045,1.35e-12,3;DOID:2531,2.53e-12,3;DOID:0060083,2.53e-12,3;DOID:1240,2.53e-12,3 | |||
|ontology_enrichment_uberon=UBERON:0002384!1.07e-08!46 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002384,1.12e-11,46;UBERON:0002204,2.03e-08,32;UBERON:0002371,4.63e-08,16 | |||
|phase1_expression=0.160148847104794,0,0,0.30246421130683,0,0,0,0.387369970324729,0,0.234064526321993,0,0,0,0,0,0,0,0,0,0,0,0.297872853602656,0.261199789138935,0,0.45881856213434,0,0,0.215471232685889,0,0,0.221730510655305,1.90509202037889,1.23012957516914,15.8481681015439,0,0,0,2.92972141515835,3.1253413780952,2.09409497589519,8.2352408324342,9.56263678941824,1.45653105909346,0,0,0,0,0,0,0,0,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,1.7997994345628,3.9554654502679,1.4209602298922,0.299600110518405,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.294628585473668,0,0.186399445825301,0,0,1.73918693221007,0,0.679971333707751,0,0,0,0,0,0,0,0,0,0,0,0.216491041011214,0,0,0,0,0,0,0,0,0,0.117588707135705,0,0,0,0,0,0,0,0,0,0,0,1.67741174308288,2.39961092397363,1.01656181658452,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0937017245597288,0,0,0,0,0,0,0,0.411564272815887,0,2.1066395619397,1.28673953557358,0.568326998791185,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.102904612379284,0,0.264450566663544,0,0,0,0,0,0.190225626112559,0,0,0,0,0,0.898819408654221,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.224862112384854,0.202860121388503,0.241177159752417,0.50925170356284,0.287696137450811,0,0.274561413188081,0,0,0,0,0,0,0,0,0,0.169745085775188,0,0,0,0,0,0,0,0,0,0.144649058581512,1.50791283939272,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164970122972535,0,0,0,0,0,0,0,0,0.356497378384721,0,0,0,2.7235168460303,0,0,0,0,0.178368817602071,0,0.608929898229199,0,0,0,0,0,0,0,0,0.291480836629851,0,0,0,0.555583582109135,0,0,0,6.11922347977879,6.9975726161829,4.28419918793714,0,0,0,0,0,0,0.134864346384821,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.183151624267265,0.428736758158132,0,0,0,0,0.171853182343688,0,0,0,0,0,0,0,0,0,0,0,0.367687016900028,0.222246727801615,0,0,0,0,0,0.0936415074698824,0,0.114870937911227,0,0,0,0,0,0,0,0,0.145346416632329,0,0.0846146078916765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr2:38392125..38392136,+ | |||
}} |
Latest revision as of 03:55, 5 August 2015
Short description: | p@chr2:38392125..38392136, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:38392125..38392136, + |
Coexpression cluster: | MCL_coexpression_mm9:2724 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
common myeloid progenitor | 7.99e-15 | 19 |
erythroid lineage cell | 2.53e-12 | 3 |
erythroblast | 2.53e-12 | 3 |
erythroid progenitor cell | 2.53e-12 | 3 |
proerythroblast | 2.53e-12 | 3 |
bone marrow cell | 3.93e-12 | 3 |
mesenchymal stem cell of the bone marrow | 3.93e-12 | 3 |
connective tissue cell | 1.12e-11 | 46 |
mesenchymal cell | 1.12e-11 | 46 |
stem cell | 3.05e-11 | 97 |
motile cell | 1.31e-09 | 54 |
hematopoietic cell | 2.91e-08 | 32 |
hematopoietic oligopotent progenitor cell | 2.91e-08 | 32 |
hematopoietic stem cell | 2.91e-08 | 32 |
hematopoietic multipotent progenitor cell | 2.91e-08 | 32 |
myeloid cell | 3.97e-08 | 16 |
somatic stem cell | 6.12e-08 | 91 |
multi fate stem cell | 6.12e-08 | 91 |
Ontology term | p-value | n |
---|---|---|
connective tissue | 1.12e-11 | 46 |
musculoskeletal system | 2.03e-08 | 32 |
bone marrow | 4.63e-08 | 16 |
Ontology term | p-value | n |
---|---|---|
organ system cancer | 2.83e-23 | 6 |
musculoskeletal system cancer | 1.35e-12 | 3 |
muscle cancer | 1.35e-12 | 3 |
hematologic cancer | 2.53e-12 | 3 |
immune system cancer | 2.53e-12 | 3 |
leukemia | 2.53e-12 | 3 |